4SC Public
Our products shall provide patients with innovative treatment options being more tolerable and efficacious than existing ones for a better quality of life.
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Founded Date:
1997
Investors Number:
9
Last Funding Date:
2019-11-12
Employee Number:
51-100
Last Funding Type:
Post-IPO Equity
Industry:
PharmTech
Headquarters:
Germany
Total Funding:
94700000 EUR